Barden Capital Management Inc. Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Barden Capital Management Inc. lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,862 shares of the company’s stock after buying an additional 82 shares during the period. Barden Capital Management Inc.’s holdings in HCA Healthcare were worth $1,163,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the company. OLD National Bancorp IN bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at $315,000. Resonant Capital Advisors LLC purchased a new stake in HCA Healthcare in the third quarter worth about $200,000. Raymond James & Associates increased its holdings in HCA Healthcare by 5.2% in the 3rd quarter. Raymond James & Associates now owns 120,759 shares of the company’s stock worth $49,080,000 after acquiring an additional 5,981 shares in the last quarter. Friedenthal Financial purchased a new stake in shares of HCA Healthcare in the third quarter worth $50,000. Finally, Dixon Mitchell Investment Counsel Inc. boosted its holdings in HCA Healthcare by 6.1% in the 3rd quarter. Dixon Mitchell Investment Counsel Inc. now owns 51,411 shares of the company’s stock worth $20,899,000 after buying an additional 2,978 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 2.2 %

NYSE HCA opened at $415.54 on Monday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $108.84 billion, a PE ratio of 20.71, a PEG ratio of 1.44 and a beta of 1.67. The company’s 50-day moving average price is $392.18 and its 200-day moving average price is $350.50. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter last year, the firm posted $4.29 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on HCA. Wells Fargo & Company increased their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. KeyCorp assumed coverage on shares of HCA Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $475.00 target price for the company. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $365.65.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.